COVID-19: WHO gives emergency approval to China's Sinopharm vaccine

COVID-19: WHO gives emergency approval to China's Sinopharm vaccine

DNA

Published

On December 30, 2020, Chinese officials, after phase three trials of Sinopharm, announced the efficacy rate of the vaccine was 79%.

Full Article